Novo Holdings Inozyme Pharma, Inc. Transaction History

Novo Holdings

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$11.12 - $19.4 $20.8 Million - $36.2 Million	-1,867,706 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$15.19 - $21.2 $1.54 Million - $2.16 Million	-101,673 Reduced 5.16%	1,867,706 $31.8 Million
Q1 2021 May 17, 2021	SELL	$17.77 - $27.9 $10.7 Million - $16.7 Million	-600,000 Reduced 23.35%	1,969,379 $39 Million
Q3 2020 Nov 16, 2020	BUY	$17.54 - $30.2 $45.1 Million - $77.6 Million	2,569,379 New	2,569,379 $67.5 Million

53.2M

3.7K

5.8K

Ticker INZY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,145,700
Market Cap $63.8M
Description
Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, ...

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

Stay updated on Novo Holdings with notifications on news.